ESTIMATED AGGREGATE TREATMENT BENEFIT WITH ADDITION OF MULTIPLE NOVEL MEDICATIONS FOR SECONDARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Saved in:
Main Authors: | Robert W. Ariss, Rajesh Gupta |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/90ecf47a6c5646ad8073255d61c6e78c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
by: Aarti Thakkar, et al.
Published: (2021) -
Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
by: Anne Mirjam Kerola, et al.
Published: (2021) -
Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
by: Charles Amir German, et al.
Published: (2020) -
Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients
by: Jiang Li, et al.
Published: (2021) -
Hypertensive Disorders in Pregnancy and the Risk of Cardiovascular Disease: A Need for Postpartum Strategies for the Primary Prevention
by: Ajay K. Gupta
Published: (2018)